Belmont, MA, United States of America

Bambang Adiwijaya

This inventor holds 3 USPTO granted patents and 7 published patent applications. Top assignees: Merrimack Pharmaceuticals, Inc., Ipsen Biopharm Limited. Active years: 2017-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bambang Adiwijaya. Retrieved from https://idiyas.com/inventor/bambang-adiwijaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Bambang Adiwijaya: Innovator in Cancer Treatment

Introduction

Bambang Adiwijaya is a prominent inventor based in Belmont, MA, who has made significant contributions to the field of cancer treatment through his innovative research. With a total of three patents to his name, Adiwijaya has focused on developing novel therapies and methods to enhance cancer patient outcomes, particularly in small cell lung cancer.

Latest Patents

Adiwijaya's latest patent is centered on "Nanoliposomal irinotecan for use in treating small cell lung cancer." This innovative therapy involves the administration of liposomal irinotecan every two weeks, potentially paired with other agents like corticosteroids and anti-emetics, aiming to improve treatment efficacy. Another noteworthy patent focuses on "Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapies." This invention outlines methods to optimize therapy for cancer patients by measuring specific biomarkers in biological samples, ultimately aiding in selecting the best treatment options based on the patient’s unique profile.

Career Highlights

Throughout his career, Bambang Adiwijaya has collaborated with reputable companies in the pharmaceutical industry, including Merrimack Pharmaceuticals, Inc. and Ipsen Biopharm Limited. His work has been pivotal in creating advanced solutions for cancer treatment that could potentially reshape therapeutic approaches in oncology.

Collaborations

Adiwijaya has worked alongside talented professionals such as Akos Czibere and William Kubasek, contributing to a collaborative environment that fosters innovation and progress in cancer research. Their combined efforts highlight the importance of teamwork in bringing groundbreaking ideas to fruition.

Conclusion

Bambang Adiwijaya exemplifies the spirit of innovation in the medical field, particularly in cancer therapy. His patents not only underscore his dedication to improving patient care but also reflect the ongoing advancements in treatment methodologies that can significantly impact the lives of individuals battling cancer. As he continues to develop new technologies and approaches, Adiwijaya remains a key figure in the realm of medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…